Late Radiation-Related Toxicities in Patients Treated for Early-Stage Cervical Carcinoma by Surgery and Adjuvant Radiotherapy: A Retrospective Imaging Study
Jazyk angličtina Země Švýcarsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
34650341
PubMed Central
PMC8506932
DOI
10.3389/pore.2021.1609915
PII: 1609915
Knihovny.cz E-zdroje
- Klíčová slova
- bone, cancer, comorbidity, complication, radiation-induced tumor, toxicity,
- MeSH
- adjuvantní radioterapie škodlivé účinky MeSH
- dospělí MeSH
- hysterektomie škodlivé účinky MeSH
- kombinovaná terapie MeSH
- lidé MeSH
- lokální recidiva nádoru patologie terapie MeSH
- nádory děložního čípku patologie terapie MeSH
- následné studie MeSH
- PET/CT metody MeSH
- počítačové zpracování obrazu metody MeSH
- prognóza MeSH
- radiační poranění diagnostické zobrazování etiologie patologie MeSH
- retrospektivní studie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Surgical treatment is preferred therapy of early-stage cervical carcinoma. In the risk of cancer recurrence surgery is often followed by adjuvant radiotherapy. In our retrospective study we aimed at identifying late (≥6 months) and very late (≥5 years) radiation adverse effects on imaging scans as CT, PET/CT and MRI in patients who underwent successful treatment for cervical carcinoma by radical surgery combined with radiotherapy ± chemotherapy. We correlated imaging results with clinical manifestations. We selected young and middle-aged patients with long life expectancy, as late radiation-related toxicities may significantly affect their quality of life. Patients were selected from those who were primary diagnosed and treated between the years 1987-2011 and regularly visited our Oncology department in years 2011-2012. Following inclusion criteria were applied: age ≤55 years at diagnosis, clinical follow-up ≥5 years and at least one tomography scan ≥3 years after finished treatment. One hundred and three subjects were reviewed: 73 patients met all inclusion criteria, while 30 patients fulfilled the inclusion criteria except for available tomography scan ≥3 years after therapy. The mean imaging follow-up was 11.2 ± 7.6 years and the mean clinical follow-up was 15.0 ± 6.9 years. In 20 (27%) subjects 27 cases grade I radiation-related toxicities were found; 9 (33%) of those 27 cases were clinically silent. In 14 (19%) females only grade I toxicities were observed. Grade III-IV toxicities were found in 5 (6.8%) subjects. No grade V toxicities were observed. We concluded that severe late side effects caused by radiotherapy were exceedingly rare in females successfully treated for early-stage cervical carcinoma, only 1 bilateral osteonecrosis, 2 cases of ileus, and 2 potentially radiation-induced tumors were found. The majority of radiation-related comorbidities found on imaging scans were clinically silent.
2nd Faculty of Medicine Charles University Prague Czechia
Institute of Anatomy 2nd Medical Faculty Charles University Prague Czechia
Zobrazit více v PubMed
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin (2021) 71:209–49. 10.3322/caac.21660 PubMed DOI
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynecol Obstet (2018) 143(Suppl. 2):22–36. 10.1002/ijgo.12611 PubMed DOI
Gaffney DK. Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy? J Gynecol Oncol (2012) 23(4):207–20. 10.3802/jgo.2012.23.4.207 PubMed DOI PMC
Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH, et al. Role of Imaging in Pretreatment Evaluation of Early Invasive Cervical Cancer: Results of the Intergroup Study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. Jco (2005) 23(36):9329–37. 10.1200/jco.2005.02.0354 PubMed DOI
Kraljević Z, Visković K, Ledinsky M, Zadravec D, Grbavac I, Bilandzija M, et al. Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings. Coll Antropol (2013) 37(2):561–8. PubMed
Viswanathan AN, Lee LJ, Eswara JR, Horowitz NS, Konstantinopoulos PA, Mirabeau-Beale KL, et al. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer (2014) 120(24):3870–83. 10.1002/cncr.28849 PubMed DOI
Singh GK, Yadav V, Singh P, Bhowmik KT. Radiation-Induced Malignancies Making Radiotherapy a "Two-Edged Sword": A Review of Literature. World J Oncol (2017) 8(1):1–6. 10.14740/wjon996w PubMed DOI PMC
Vale C, Tierney JF, Stewart LA, Brady M, Dinshaw K, Jakobsen A, et al. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. Jco (2008) 26(35):5802–12. 10.1200/jco.2008.16.4368 PubMed DOI PMC
Malikova H, Burghardtova M, Fejfarova K, Nadova K, Weichet J. Advanced cervical cancer in young women: imaging study of late and very late radiation-related side effects after successful treatment by combined radiotherapy. Quant Imaging Med Surg (2021) 11(1):21–31. 10.21037/qims-20-553 PubMed DOI PMC
Yuce Sari S, Guler OC, Gultekin M, Onal HC, Yildiz F. Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is it Sufficient? Oncol Res Treat (2017) 40(9):523–7. 10.1159/000476037 PubMed DOI
Common terminology criteria for adverse events v5.0 Available at: www.meddra.org (Accessed Jan 6, 2021).
Yu H, Zhang L, Du X, Sheng X. Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors. Ott (2016) Vol. 9:7331–5. 10.2147/ott.s107146 PubMed DOI PMC
Dávila Fajardo R, van Os R, Buist MR, Uitterhoeve L, Westermann AM, Kenter GG. Postoperative radiotherapy in patients with early stage cervical cancer. Gynecol Oncol (2014) 134:52–9. 10.1016/j.ygyno.2014.04.045 PubMed DOI
Braunstein S, Nakamura JL. Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk. Front Oncol (2013) 3:73. 10.3389/fonc.2013.00073 PubMed DOI PMC
Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW, Coley BL. Sarcoma arising in irradiated bone: report of eleven cases. Cancer (1998) 82(1):8–34. 10.1002/(sici)1097-0142(19980101)82:1<8:aid-cncr3>3.0.co;2-w PubMed DOI
Hall EJ, Wuu CS. Radiation -induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys (2003) 56(1):83–8. 10.1016/s0360-3016(03)00073-7 PubMed DOI
Kwon JW, Huh SJ, Yoon YC, Choi SH, Jung JY, Oh D, et al. Pelvic bone complications after radiation therapy of uterine cervical cancer: evaluation with MRI. Am J Roentgenol (2008) 191(4):987–94. 10.2214/ajr.07.3634 PubMed DOI
Papadopoulou I, Stewart V, Barwick TD, Park WH, Soneji N, Rockall AG, et al. Post-Radiation Therapy Imaging Appearances in Cervical Carcinoma. Radiographics (2016) 36(2):538–53. 10.1148/rg.2016150117 PubMed DOI
Lundin B, Bjorkholm E, Lundell M, Jacobsson H. Insufficiency fractures of the sacrum after radiotherapy for gynecological malignancy. Acta Oncol (1990) 29:211–5. 10.3109/02841869009126547 PubMed DOI
Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, et al. Pelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer (2010) 116(3):625. 10.1002/cncr.24811 PubMed DOI PMC